Accueil
Explorer
nav.journalClub
Tendances
Plus
synapse
⌘+K
Langue
Français
Français
Using intravesical botulinum toxin as an adjunct during urologic surgery: a systematic review | Synapse
March 3, 2026
Using intravesical botulinum toxin as an adjunct during urologic surgery: a systematic review
SR
Suditi Rahematpura
JM
Joanna Marantidis
AW
Amanda Wibben
See all
Key Points
Adjunctive use of intravesical botulinum toxin may enhance surgical outcomes in urologic procedures, improving patient recovery.
Systematic review reveals better postoperative results with botulinum toxin, favoring patients undergoing bladder-related surgeries.
Analysis of multiple studies indicates the effectiveness of botulinum toxin as an adjunct in urologic surgery settings.
Findings highlight the need for further exploration of botulinum toxin's role in various surgical approaches within urology.
Mark Helpful
Like
Save
Bookmark
Relay
Share
Mark Helpful
Like
Save
Bookmark
Relay
Share
Cite This Study
Copy
Rahematpura et al. (Thu,) studied this question.
synapsesocial.com/papers/69a75d99c6e9836116a27c69
https://doi.org/https://doi.org/10.1007/s00345-025-06136-9